Industries > Pharma > Global Neurostimulation Devices Market 2019-2029

Global Neurostimulation Devices Market 2019-2029

Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Cortical Stimulators, Epilepsy, Pain Management, Hearing Loss, Incontinence, Gastroparesis, Parkinson’s Disease

PUBLISHED: 28 November 2018
PAGES: 166
PRODUCT CODE: PHA0344

Clear
WOOCS 2.2.1
SKU: PHA0344 Categories: , , Tags: , , ,

The global neurostimulation devices market will reach $13bn in 2024 and is estimated to grow at a CAGR of 13% from 2024 to 2029. In 2018, the spinal cord stimulators segment accounted for 45% of the global neurostimulation devices market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 166-page report you will receive 102 charts– all unavailable elsewhere.

The 166-page report provides clear detailed insight into the neurostimulation devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Neurostimulation Devices Market from 2019-2029

• Forecast of the Global Neurostimulation Devices market by Product:
• Spinal Cord Stimulators
• Deep Brain Stimulators
• Sacral Nerve Stimulators
• Vagus Nerve Stimulators
• Cortical Stimulators
• Others

Each submarket is further segmented by regional and national market: US, Canada, Germany, France, the UK, Italy, Spain, Rest of Europe, Japan, China, India, Rest of APAC, Latin America, Middle East & Africa

• Forecast of the Global Neurostimulation Devices market by Application:
• Pain Management
• Epilepsy
• Urinary and Fecal Incontinence
• Hearing Loss
• Gastroparesis
• Parkinson’s Disease
• Others

Each submarket is further segmented by regional and national market: US, Canada, Germany, France, the UK, Italy, Spain, Rest of Europe, Japan, China, India, Rest of APAC, Latin America, Middle East & Africa

• This report provides individual revenue forecasts to 2028 for these regional and national markets:
• North America: US, Canada
• Europe: Germany, France, United Kingdom, Italy, Spain and rest of Europe
• Asia-Pacific: Japan, China, India and rest of Asia-Pacific
• RoW: Latin America, Middle East & Africa

Global Neurostimulation Devices Market 2019-2029

• Our study discusses the selected leading companies that are the major players in the neurostimulation devices market:
• Advanced Bionics
• Boston Scientific Corporation
• Cochlear ltd
• Cyberonics
• Medtronic
• Neuronetics Inc
• Nervo Corp.
• Cogentic Medical Inc
• St Jude Medical
• NDI Medical

• Our study discusses the factors that drive and restrain the neurostimulation devices market:

Visiongain’s study is intended for anyone requiring commercial analyses for the neurostimulation devices market. You find data, trends and predictions.

Buy our report today Neurostimulation Devices Market 2019-2029: Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Cortical Stimulators, Epilepsy, Pain Management, Hearing Loss, Incontinence, Gastroparesis, Parkinson’s Disease

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Neurostimulation Devices Market 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Neurostimulation Devices Market 2019-2029


Latest Pharma news

Visiongain Publishes Biological API Manufacturing Services Market Report 2021-2031

Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.

08 January 2021

READ

Visiongain Publishes Anaesthesia & Respiratory Devices Market Report 2020-2030

The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.

07 January 2021

READ

Visiongain Publishes Inactivated Vaccines Market Report 2020-2030

Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.

07 January 2021

READ

Visiongain Publishes Human Microbiome Therapeutics Market Report 2021-2031

The potential of microbiome-based drugs as novel treatments to address the unmet needs for many diseases has contributed intensively to the rapid emergence of many investors in this area. Currently, no regulatory framework exists and no drugs have received FDA approval. However, there are several preclinical and clinical-stage companies working with various approaches to develop microbiome-based therapies.

06 January 2021

READ

Categories

Category